p-methoxy-n-methylphenethylamine has been researched along with chitosan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, MJ; Brea, J; Loza, MI; Oyarzun-Ampuero, FA; Torres, D | 1 |
| Bento, D; Borchard, G; Borges, O; Gonçalves, T | 1 |
| Bento, D; Borges, O; Gonçalves, T; Staats, HF | 1 |
3 other study(ies) available for p-methoxy-n-methylphenethylamine and chitosan
| Article | Year |
|---|---|
Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Topics: Algorithms; Animals; Anti-Asthmatic Agents; Asthma; Cell Degranulation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Stability; Endocytosis; Female; Heparin; Heparin, Low-Molecular-Weight; Histamine Release; Hyaluronic Acid; Inhibitory Concentration 50; Mast Cells; Nanoparticles; p-Methoxy-N-methylphenethylamine; Particle Size; Rats; Rats, Sprague-Dawley | 2009 |
Validation of a new 96-well plate spectrophotometric method for the quantification of compound 48/80 associated with particles.
Topics: Acetaldehyde; Adjuvants, Immunologic; Alginates; Calibration; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Equipment Design; Hydrogen-Ion Concentration; Limit of Detection; Linear Models; Microspectrophotometry; Miniaturization; Nanoparticles; Nitroprusside; p-Methoxy-N-methylphenethylamine; Reference Standards; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical; Water | 2013 |
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Alginates; Animals; Anthrax; Anthrax Vaccines; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Toxins; Biomarkers; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Female; Glucuronic Acid; Hexuronic Acids; Humans; Immunity, Mucosal; Immunization; Mast Cells; Mice; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Nasal Mucosa; p-Methoxy-N-methylphenethylamine; Particle Size; RAW 264.7 Cells; Surface Properties; T-Lymphocytes, Helper-Inducer; Technology, Pharmaceutical; Time Factors | 2015 |